Imperva (IMPV) Tops Q2 EPS by 13c, Q3 & FY Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
Go back to Imperva (IMPV) Tops Q2 EPS by 13c, Q3 & FY Guidance Beats
August 7, 2015 10:22 AM EDT
Pacific Crest maintained an Overweight rating on Imperva (NYSE: IMPV) and raised its price target to $80.00 (from $67.00). The change follows strong Q2 results and guidance.
Analyst Rob Owens said, "We are increasing our target and remain buyers of IMPV. Improving execution and a... More
August 7, 2015 7:47 AM EDT
Needham & Company analyst Scott Zeller reiterated a Buy rating and boosted his price target on Imperva (NYSE: IMPV) to $88.00 (from $67.00) after a strong June quarter.
Zeller commented, "The IMPV JuneQ results were very strong, and license accelerated (a bit)... More
August 7, 2015 7:03 AM EDT
Oppenheimer reiterated an Outperform rating on Imperva (NYSE: IMPV), and raises the price target to $80.00 (from $75.00), following 2Q15 results. Revenue of $53.5M (up 39% YoY) bested consensus $48.7M estimate. Loss per share of $0.08 came in better than our and Street's estimate of $0.21. For... More
